Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 10/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 10/20 | 0.73 |
| ▸ | RAB9A | P51151 | 7/20 | 0.73 |
| ▸ | NPC1 | O15118 | 5/20 | 0.73 |
| ▸ | HTT | P42858 | 5/20 | 0.73 |
| ▸ | MAPT | P10636 | 5/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.73 |
| ▸ | STAT3 | P40763 | 1/20 | 0.73 |
| ▸ | KDM4A | O75164 | 4/20 | 0.58 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.58 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.52 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.52 |
| ▸ | GFER | P55789 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 3/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3866926 | 0.99 | MEN1 (0.71) | MEN1KMT2ARAB9ANPC1HTT | |
| Hydrochloric Acid SCHEMBL3866923 | 0.99 | MEN1 (0.71) | MEN1KMT2ARAB9ANPC1HTT | |
| Hydrochloric Acid SCHEMBL3866925 | 0.99 | MEN1 (0.71) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL10104174 | 0.93 | MEN1 (0.64) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL10104170 | 0.91 | MEN1 (0.65) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL12657105 | 0.90 | MEN1 (0.64) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL10313112 | 0.89 | MEN1 (0.62) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL10104042 | 0.88 | MEN1 (0.68) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL10104097 | 0.87 | MEN1 (0.60) | MEN1KMT2ARAB9ANPC1HTT | |
| SCHEMBL12657238 | 0.86 | MEN1 (0.69) | MEN1KMT2ARAB9ANPC1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2018848-B2 | Hair composition comprising at least one fluorescent dye and at least one alkali hydroxide agent and method of simultaneous styling, dyeing and/or lightening. | ORÉAL L (FR) | 2016-08-31 | — | — | EP | disclosed |
| US-7601180-B2 | Use for the dyeing with lightening effect of keratin substances of a composition comprising a fluorescent cyanine dye | L'OREAL S.A. (FR) | 2009-10-13 | — | — | US | disclosed |
| US-20090049621-A1 | USE FOR THE DYEING WITH LIGHTENING EFFECT OF KERATIN SUBSTANCES OF A COMPOSITION COMPRISING A FLUORESCENT CYANINE DYE | L'OREAL S.A. (FR) | 2009-02-26 | — | — | US | disclosed |
| EP-2018848-A2 | Hair composition comprising at least one fluorescent dye and at least one alkali hydroxide agent and method of simultaneous styling, dyeing and/or lightening. | L'Oreal (FR) | 2009-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090049621-A1 | USE FOR THE DYEING WITH LIGHTENING EFFECT OF KERATIN SUBSTANCES OF A COMPOSITION COMPRISING A FLUORESCENT CYANINE DYE | KRT18, S100A4, S100P | MEN1 2692/4885KMT2A 1544/4885RAB9A 4477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.